Literature DB >> 28499829

Characteristics of traditional Chinese medicine usage in children with precocious puberty: A nationwide population-based study.

Yi-Chun Lin1, Tung-Ti Chang2, Husan-Ju Chen3, Chung-Hsing Wang4, Mao-Feng Sun5, Hung-Rong Yen6.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Precocious puberty (PP) occurs in children with the early onset of pubertal development leading to physical and psychological problems. Current medical treatment is expensive and has its side effects. However, little is known about the utilization of traditional Chinese medicine (TCM) among patients with PP. To characterize the application of TCM among these patients, we conducted a nationwide population-based study.
MATERIALS AND METHODS: We used the Taiwanese National Health Insurance Research Database (NHIRD), to perform a nationwide population-based study. The NHIRD has a derived dataset with the information for a randomly selected half of all insured children from 1997 to 2008 in Taiwan. We identified children <18 years of age with newly diagnosed sexual precocity (ICD-9 CM code: 259.1). The subjects were categorized based on the inclusion of TCM in their treatment plan.
RESULTS: Overall, 3495 newly diagnosed subjects with sexual precocity were included. Among these children, 1.86% (N=65) had used TCM. There were significantly more subjects with no treatment, 87.32% (N=3052), than those with treatment of TCM, western medicine, or both. Most of the TCM users received Chinese herbal remedies (98.25%), and only 1.75% received acupuncture or manipulative therapies. Zhi-Bai-Di-Huang-Wan was the most frequently prescribed TCM formulation (23.73%), while Mai-Ya (Fructus Hordei Germinatus) was the most commonly prescribed single herb (10.87%).
CONCLUSION: Our study identified the characteristics and prescription patterns of TCM for children with PP in Taiwan. Further basic mechanistic studies and clinical trials are needed to confirm the efficacy and mechanism.
Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Fructus Hordei Germinatus; National Health Insurance Research Database; Precocious Puberty; Traditional Chinese Medicine; Zhi-Bai-Di-Huang-Wan

Mesh:

Substances:

Year:  2017        PMID: 28499829     DOI: 10.1016/j.jep.2017.05.006

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  5 in total

1.  Herbal medicine for idiopathic central precocious puberty: A protocol for a systematic review of controlled trials.

Authors:  Hye Lim Lee; Yoo Been Lee; Jun-Yong Choi; Ju Ah Lee
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

2.  Prescription patterns of traditional Chinese medicine amongst Taiwanese children: a population-based cohort study.

Authors:  Hwey-Fang Liang; Yao-Hsu Yang; Pau-Chung Chen; Hsing-Chun Kuo; Chia-Hao Chang; Ying-Hsiang Wang; Kuang-Ming Wu
Journal:  BMC Complement Altern Med       Date:  2018-06-22       Impact factor: 3.659

Review 3.  Polygonum multiflorum-Induced Liver Injury: Clinical Characteristics, Risk Factors, Material Basis, Action Mechanism and Current Challenges.

Authors:  Yi Liu; Wenping Wang; Mingyi Sun; Baorui Ma; Linnuo Pang; Yuanyuan Du; Xiaoxv Dong; Xingbin Yin; Jian Ni
Journal:  Front Pharmacol       Date:  2019-12-13       Impact factor: 5.810

4.  Preventive Effect of Anemarrhenae rhizome and Phellodendri cortex on Danazol-Induced in Precocious Puberty in Female Rats and Network Pharmacological Analysis of Active Compounds.

Authors:  Kyeong Ri Kim; Tuy An Trinh; Ji Yun Baek; Dahae Lee; Sehun Lim; Jonghyup Kim; Won-Yung Lee; Chang-Eop Kim; Ki Sung Kang; Hye Lim Lee
Journal:  Plants (Basel)       Date:  2021-12-22

5.  Precocious Puberty and the Lin28/Let7 Pathway: The Therapeutic Effect of the Nourishing "Yin" and Purging "Fire" Traditional Chinese Medicine Mixture in a Rat Model.

Authors:  Yuanyuan He; Xinghui Han; Wen Sun; Jian Yu; Amin Tamadon
Journal:  Evid Based Complement Alternat Med       Date:  2018-06-26       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.